68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
NCT07209865
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer (Adenocarcinoma)
Interventions
DRUG:
68Ga-P16-093
Sponsor
First Affiliated Hospital of Fujian Medical University